|
Patterns
of Resistance Mutations to Antiretroviral Drugs in Extensively Treated
HIV-1-Infected Patients with Failure of Highly Active Antiretroviral
Therapy [Rousseau M-N, et al. JAIDS 2001;26:36]
posted 1/30/2001
Health
Care Financing Administration (HCFA) Requests State Medicaid Plans
to Cover Costs of Genotype and Phenotype Resistance Tests
[[Letter from HCFA to Medicaid Directors, January 8, 2001]
posted 1/30/2001
FDA
and Bristol Myers Squibb Warn Against the Use of Zerit in Combination
with Videx in HIV-Infected Pregnant Patients due to Potential Increased
Risk of Lactic Acidosis [FDA talk paper T01-02, 1/5/01]
posted 1/26/2001
A
Randomized Trial of the Discontinuation of Primary and Secondary
Prophylaxis Against Pneumocystis carinii Pneumonia After
Highly Active Antiretroviral Therapy in Patients with HIV Infection
[Lopez JC, et al. NEJM 2001;344:159]
posted 1/26/2001
Diagnosing
Primary HIV Infection: HIV RNA more Sensitive but Less Specific
than p24 Antigen [Daar ES, et al. Ann Intern Med
2001;134:25]
posted 1/18/2001
Association
of Initial CD4 Cell Count and Viral Load With Response to Highly
Active Antiretroviral Therapy [Chaisson RE, et al. JAMA
2000;284:3128]
posted 1/18/2001
HIV/AIDS
Surging in Eastern Europe [Stephenson J. JAMA 2000;284:3113]
posted 1/18/2001
Generalized
Tuberculosis in the Acquired Immune Deficiency Syndrome
[Smith MB, et al. Arch Path Lab Med 2000;124:1267]
posted 1/18/2001
Plasma
Viral Load in HIV-1 and HIV-2 Singly and Dually Infected Individuals
in Guinea-Bissau, West Africa [Andersson S, et al. Arch
Intern Med 2000;160:3286]
posted 1/18/2001
Full
Funding for Ricky Ray Trust Fund Provided in Final Budget Bill
posted 1/18/2001
Occupational
Transmission of Human Immunodeficiency Virus and Hepatitis C Virus
After a Punch [Abel S, et al. CID 2000;31:1494]
posted 1/18/2001
Osteonecrosis
Complicating Highly Active Antiretroviral Therapy in Patients Infected
with Human Immunodeficiency Virus [Monier P, et al. CID
2000;31:1488]
posted 1/18/2001
The
Human Immunodeficiency Virus-Infected Traveler [Castelli
F and Patroni A. CID 2000;31:1403]
posted 1/18/2001
Serious
Adverse Events Attributed to Nevirapine Regimens for Postexposure
Prophylaxis After HV Exposures - Worldwide, 1997 - 2000
[MMWR 2001;49:1153]
posted 1/18/2001
SUDS
HIV-1 Test (Murex) Not Available [Letter from Abbott Diagnostics,
Oct. 17, 2000]
posted 1/18/2001
Human
Immunodeficiency Virus Type 1 Quasi Species that Rebound After Discontinuation
of Highly Active Antiretroviral Therapy are Similar to the Viral
Quasi Species Present Before Initiation of Therapy [Imamichi
H, et al. JID 2001;183:36]
posted 1/18/2001
Despite
High Concordance, Distinct Mutational and Phenotypic Drug Resistance
Profiles in Human Immunodeficiency Virus Type 1 RNA are Observed
in Gastrointestinal Mucosal Biopsy Specimens and Peripheral Blood
Mononuclear Cells Compared with Plasma [Poles MA, et al.
JID 2001;183:143]
posted 1/18/2001
Pharmacological
Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine,
and Indinavir [Kakuda TN, et al. AAC 2001;45:236]
posted 1/18/2001
Differential
Impact of Combined Antiretroviral Therapy on the Survival of Italian
Patients with Specific AIDS-Defining Illnesses [Conti S,
et al. JAIDS 2001;25:451]
posted 1/18/2001
"Blood
Heads" and AIDS Haunt China's Countryside [Beach MV. Lancet
2001;357:49]
posted 1/18/2001
Shortage
of Ganciclovir Capsules
posted 1/18/2001
Federal
Budget for HIV/AIDS for FY2001
posted 1/18/2001
Federal
spending for HIV/AIDS for FY2000 [AIDS Reference Guide,
December 2000, p. 301]
posted 1/4/2001
HIV
Post-exposure Prophylaxis Registry: Results with 492 events
[Wang SA, et al. Infect Contr Hosp Epidemiol 2000;21:780]
posted 1/4/2001
Community-acquired
Bacterial Pneumonia in Persons with HIV Infection [Cordero
E, et al. Am J Respir Crit Care Med 2000;162:2063]
posted 1/4/2001
Safety
of Protease Inhibitors in Pregnancy [Morris AB, et al.
JAIDS 2000;25:306]
posted 1/4/2001
Ritonavir-Nelfinavir
Combination Therapy [Raines CP, et al. JAIDS 2000;
25:322]
posted 1/4/2001
HCV
Coinfection May Blunt CD4 cell Response to HAART [Greub
G, et al. Lancet 2000; 356;1800]
posted 1/4/2001
Low-dose
Daily IL-2 with HAART [Lalezari JP, et al. HIV Clin
Trials 29991l1(3):1]
posted 1/4/2001
Absence
of Maternal-fetal Transmission of HIV in Second Trimester
[Pedreno AP, et al. Am J Obstet Gynec 2000;183:638]
posted 1/4/2001
Hepatotoxicity
of PIs in Patients with HCV Coinfection [Saves M, et al.
Antimicrob Ag Chemother 2000;44:3451]
posted 1/4/2001
FDA
Issues Safety Warning on Stolen Goat Serum [Press Release
by the FDA, December 22, 2000]
posted 1/4/2001
 archive
|
